SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 28, 2026

FLGT

Fulgent Genetics, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago
Insider cluster: 2 insiders, $38K total
Actionable Insight • Neutral

No actionable trading signal from this cluster. Dollar amounts are trivial and no C-suite buying offsets the selling. Monitor the next 10-Q (expected late July) for fundamental trends in Fulgent's laboratory services revenue, which is the primary stock driver.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
FLGT ▲ +7.22% at T+60d
NEUTRAL call +7.22% · α vs SPY +6.04% · entry $18.14 → $19.45
Entry = T+0 close
May 28, 2026
via day close
T+1d
-0.28%
call -0.28% · α -0.55%
$18.09
settled 5mo ago
T+5d
0.00%
call 0.00% · α +0.29%
$18.14
settled 5mo ago
T+20d
+13.18%
call +13.18% · α +14.97%
$20.53
settled 4mo ago
T+60d
+7.22%
call +7.22% · α +6.04%
$19.45
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

A cluster of insider selling at Fulgent Genetics: the President/COO sold ~$21K and the CSO sold ~$17K in open-market transactions on May 27, 2026, followed by tax-withholding surrenders by the CEO and CFO on June 1. The open-market sales total $38K (~0.007% of market cap) — well below any materiality threshold. These are not predictive cluster sells per academic literature; the dollar amounts are trivial for a $531M company and no C-suite open-market buying occurred.

Key Financial Metrics

Direction
selling
Total Value
$38.0K
Insiders
4

Key Facts

  • Open-market sales total ~$38K, or ~0.007% of $531M market cap — negligible proportionality
  • President/COO sold 2,146 shares total across two days at $17.60-$17.89
  • CSO sold 1,688 shares at $17.89 on June 2 plus 945 shares at $17.60 on May 27
  • CEO and CFO transactions are non-cash tax withholdings ($79K and $38K) — no economic signal
  • No insider open-market purchases in this cluster; past 30 days show $106K in total insider selling

Financial Impact

$38K open-market sales out of $531M market cap — de minimis

insider ownershipfloat

Risk Factors

  • Insider selling could accelerate if the stock rallies; watch for >$500K in open-market sales within a week as a more material signal
  • No filings cross-referencing upcoming catalysts — this appears to be routine portfolio diversification / tax-related selling

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-FLGT-1780522198245
3 reports for FLGT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FLGT — sortable, filterable
TypeNow
May 28, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.14 $19.45▲ +7.22%▲ +6.04%$20.41 (+12.51%)
May 28, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.14 $19.45▲ +7.22%▲ +6.04%$20.41 (+12.51%)
May 21, 2026
22w ago
8-K
BULLISH ★ 7/10
$17.11 $18.57▲ +8.53%▲ +5.34%$20.41 (+19.29%)
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026